Comparative study between sugammadex and neostigmine

Comparative study between sugammadex and neostigmine for the reversal of neuromuscular block in pediatric patients undergoing lower abdominal surgeries.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201511001296403

Enrollment

Registered

2015-10-06

Start date

2015-10-12

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Paediatrics neuromuscular blockade

Interventions

sugammadex group

neostagmine group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) class I or II pediatric patients aged 2-10 years undergoing lower abdominal surgeries.

Exclusion criteria

Exclusion criteria: Body mass index more than 40 kg/m2, liver or kidney disease, history of malignant hyperthermia, neuromuscular disease, history of hypersensitivity to any of the study drugs and mental retardation.

Design outcomes

Primary

Measure	Time frame
Time to reach TOF ratio greater than 0.90 wil be recorded;Number of patients needing another dose of sugammadex to reach TOF greater than 0.90;Extubation time	—

Secondary

Measure	Time frame
Adverse events;Body temperature	—

Countries

Egypt

Contacts

Public Contactkhaled mahmoud

Professor in anesthesiology, Minoufiya University

mahmoudk16@yahoo.com+201223436409

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026